Trial · NCT03204786
Adverse event totals21
The totals the trial posted for each group.
1 to 20 of 21
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Vasopressin-Vasopressin Group - Treatment Period 1 | 0 | 22 |
| Total, all-cause mortality | Placebo-Vasopressin Group - Treatment Period 1 | 0 | 42 |
| Total, all-cause mortality | Placebo-Placebo Group - Treatment Period 1 | 0 | 39 |
| Total, all-cause mortality | Vasopressin-Vasopressin Group - Treatment Period 2 | 0 | 21 |
| Total, all-cause mortality | Placebo-Vasopressin Group - Treatment Period 2 | 0 | 38 |
| Total, all-cause mortality | Placebo-Placebo Group - Treatment Period 2 | 0 | 39 |
| Total, all-cause mortality | Open-label Vasopressin | 0 | 32 |
| Total, other adverse events | Vasopressin-Vasopressin Group - Treatment Period 1 | 12 | 22 |
| Total, other adverse events | Placebo-Vasopressin Group - Treatment Period 1 | 31 | 42 |
| Total, other adverse events | Placebo-Placebo Group - Treatment Period 1 | 29 | 39 |
| Total, other adverse events | Vasopressin-Vasopressin Group - Treatment Period 2 | 15 | 21 |
| Total, other adverse events | Placebo-Vasopressin Group - Treatment Period 2 | 24 | 38 |
| Total, other adverse events | Placebo-Placebo Group - Treatment Period 2 | 26 | 39 |
| Total, other adverse events | Open-label Vasopressin | 20 | 32 |
| Total, serious adverse events | Vasopressin-Vasopressin Group - Treatment Period 1 | 0 | 22 |
| Total, serious adverse events | Placebo-Vasopressin Group - Treatment Period 1 | 0 | 42 |
| Total, serious adverse events | Placebo-Placebo Group - Treatment Period 1 | 0 | 39 |
| Total, serious adverse events | Vasopressin-Vasopressin Group - Treatment Period 2 | 0 | 21 |
| Total, serious adverse events | Placebo-Vasopressin Group - Treatment Period 2 | 0 | 38 |
| Total, serious adverse events | Placebo-Placebo Group - Treatment Period 2 | 0 | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204786/event-totals